A meta-analysis of the efficacy and safety of stereotactic arrhythmia radioablation (STAR) in patients with refractory ventricular tachycardia
Reports of stereotactic arrhythmia radioablation (STAR) in patients with refractory ventricular tachycardia after catheter ablation are limited to small series. Here, we carried out a systematic review and meta-analysis of studies to better determine the efficacy and toxicity of STAR for ventricular tachycardia.
Source: Clinical Oncology - Category: Radiology Authors: Gustavo A. Viani, Andre G. Gouveia, Juliana F. Pavoni, Alexander Vicent Louie, Jay Detsky, Daniel E. Spratt, Fabio Y. Moraes Tags: Original Article Source Type: research
More News: Arrhythmia | Cancer & Oncology | Radiology | Study | Toxicology | Ventricular Tachycardia